R Champlin
Overview
Explore the profile of R Champlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
246
Citations
3505
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu E, Tong Y, Dotti G, Shaim H, Savoldo B, Mukherjee M, et al.
Leukemia
. 2017 Jul;
32(2):520-531.
PMID: 28725044
Chimeric antigen receptors (CARs) have been used to redirect the specificity of autologous T cells against leukemia and lymphoma with promising clinical results. Extending this approach to allogeneic T cells...
2.
El Boghdadly Z, Oran B, Jiang Y, Rondon G, Champlin R, Kontoyiannis D
Bone Marrow Transplant
. 2016 Dec;
52(3):476-479.
PMID: 27941772
No abstract available.
3.
Nieto Y, Tu S, Bassett R, Jones R, Gulbis A, Tannir N, et al.
Ann Oncol
. 2015 Oct;
26(12):2507-8.
PMID: 26487577
No abstract available.
4.
Cornelison A, Saliba R, Afrough A, Dinh Y, Nieto Y, Bashir Q, et al.
Bone Marrow Transplant
. 2015 Oct;
51(2):307-9.
PMID: 26479980
No abstract available.
5.
Hosing C, Bassett R, Dabaja B, Talpur R, Alousi A, Ciurea S, et al.
Ann Oncol
. 2015 Sep;
26(12):2490-5.
PMID: 26416896
Background: Cutaneous T-cell lymphomas (CTCLs) and its common variants mycosis fungoides (MF) and leukemic Sézary syndrome (SS) are rare extranodal non-Hodgkin's lymphomas. Patients who present with advanced disease and large-cell...
6.
Nieto Y, Tu S, Bassett R, Jones R, Gulbis A, Tannir N, et al.
Ann Oncol
. 2015 Jul;
26(10):2125-32.
PMID: 26199392
Background: High-dose chemotherapy (HDC) using sequential cycles of carboplatin/etoposide is curative for relapsed germ-cell tumors (GCT). However, outcomes of high-risk patients in advanced relapse remain poor. We previously developed a...
7.
Kongtim P, Qazilbash M, Shah J, Hamdi A, Shah N, Bashir Q, et al.
Bone Marrow Transplant
. 2015 Mar;
50(5):668-72.
PMID: 25730192
Cardiac involvement in light-chain amyloidosis (AL) predicts poor prognosis and is associated with higher TRM and morbidity during high-dose therapy and auto-SCT (HDT-ASCT). We studied the outcomes of 30 patients...
8.
Parmar S, Kongtim P, Champlin R, Dinh Y, Elgharably Y, Wang M, et al.
Bone Marrow Transplant
. 2014 Jun;
49(8):1036-41.
PMID: 24887378
Optimal treatment approach continues to remain a challenge for systemic light chain amyloidosis (AL). So far, Auto-SCT is the only modality associated with long-term survival. However, failure to show survival...
9.
Parmar S, de Lima M, Worth L, Petropoulos D, Lee D, Cooper L, et al.
Bone Marrow Transplant
. 2014 May;
49(8):1109-12.
PMID: 24797184
No abstract available.
10.
Patel K, Nusrat M, Shah N, Bashir Q, Parmar S, Shah J, et al.
Bone Marrow Transplant
. 2014 Jan;
49(3):465-6.
PMID: 24419515
No abstract available.